» Authors » Claudia N Montero-Menei

Claudia N Montero-Menei

Explore the profile of Claudia N Montero-Menei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 1085
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Riaud M, Hilairet G, Sindji L, Perdomo L, Montero-Menei C, Martinez M
Eur J Pharm Biopharm . 2021 Nov; 169:268-279. PMID: 34748934
Despite the curative approaches developed against myocardial infarction, cardiac cell death causes dysfunctional heart contractions that depend on the extent of the ischemic area and the reperfusion period. Cardiac regeneration...
2.
Rmaidi A, Zelzer M, Sindji L, Dima R, Boury F, Delorme N, et al.
Mater Sci Eng C Mater Biol Appl . 2021 Feb; 121:111852. PMID: 33579486
Polymeric, biodegradable, microspheres (MS) presenting a biomimetic surface of extracellular matrix (ECM) proteins are currently used for transporting cells and/or encapsulated proteins for regenerative medicine studies. They can be made...
3.
Riaud M, Martinez M, Montero-Menei C
Pharmaceutics . 2020 Dec; 12(12). PMID: 33317141
Clinical studies have demonstrated the regenerative potential of stem cells for cardiac repair over the past decades, but their widespread use is limited by the poor tissue integration and survival...
4.
Ugur D, Sottile V, Montero-Menei C, Boury F, Zelzer M
Biointerphases . 2020 Aug; 15(4):041008. PMID: 32752604
Protein-coated polymer-based microparticles are attractive supports for cell delivery, but the interplay between microparticle properties, protein coating, and cell response is poorly understood. The interest in alternative microparticle formulations increases...
5.
Kandalam S, De Berdt P, Ucakar B, Vanvarenberg K, Bouzin C, Gratpain V, et al.
Int J Pharm . 2020 Jul; 587:119685. PMID: 32712253
There is no treatment for spinal cord injury (SCI) that fully repairs the damages. One strategy is to inject mesenchymal stem cells around the lesion to benefit from their immunomodulatory...
6.
Fares M, Cochet-Bernoin M, Gonzalez G, Montero-Menei C, Blanchet O, Benchoua A, et al.
J Neuroinflammation . 2020 Mar; 17(1):76. PMID: 32127025
Background: Tick-borne encephalitis virus (TBEV) is a member of the Flaviviridae family, Flavivirus genus, which includes several important human pathogens. It is responsible for neurological symptoms that may cause permanent...
7.
Andre E, Delcroix G, Kandalam S, Sindji L, Montero-Menei C
Pharmaceutics . 2019 Oct; 11(10). PMID: 31614758
For Huntington's disease (HD) cell-based therapy, the transplanted cells are required to be committed to a neuronal cell lineage, survive and maintain this phenotype to ensure their safe transplantation in...
8.
Ferraris P, Cochet M, Hamel R, Gladwyn-Ng I, Alfano C, Diop F, et al.
Emerg Microbes Infect . 2019 Jul; 8(1):1003-1016. PMID: 31282298
Zika virus (ZIKV) is a mosquito-borne Flavivirus that causes Zika disease with particular neurological complications, including Guillain-Barré Syndrome and congenital microcephaly. Although ZIKV has been shown to directly infect human...
9.
Autier L, Clavreul A, Cacicedo M, Franconi F, Sindji L, Rousseau A, et al.
Acta Biomater . 2018 Nov; 84:268-279. PMID: 30465922
Glioblastoma (GB) is a highly infiltrative tumor, recurring, in 90% of cases, within a few centimeters of the surgical resection cavity, even with adjuvant chemo/radiotherapy. Residual GB cells left in...
10.
Hoareau L, Fouchet F, Planesse C, Mirbeau S, Sindji L, Delay E, et al.
J Tissue Eng Regen Med . 2018 Apr; 12(6):1363-1373. PMID: 29656608
We propose a regenerative solution in the treatment of critical limb ischaemia (CLI). Poly-lactic/glycolic acid microcarriers were prepared and coated with laminin to be sterilized through γ-irradiation of 25 kGy...